Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.14% Nasdaq Up0.55%

Seattle Genetics Inc. (SGEN)

-NasdaqGS
39.31 Up 0.74(1.92%) 1:44PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 269,264   210,812   94,778  
Cost of Revenue13,759  11,546  3,115  
Gross Profit 255,505   199,266   91,663  
Operating Expenses
Research Development218,627  170,297  163,396  
Selling General and Administrative92,354  84,300  72,659  
Non Recurring7,385  1,923   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (62,861) (57,254) (144,392)
Income from Continuing Operations
Total Other Income/Expenses Net341  3,472  (7,638)
Earnings Before Interest And Taxes(62,520)(53,782)(152,030)
Interest Expense -   -   -  
Income Before Tax(62,520)(53,782)(152,030)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(62,520)(53,782)(152,030)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (62,520) (53,782) (152,030)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (62,520) (53,782) (152,030)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.